ArticleResearch square2025
Prevalence of Oral Human Papilloma virus infection in an East African HIV/AIDS cohort: A cross-sectional study.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
10 authors.
Funding
Abstract
Background: Little is known about the prevalence of Oral Human Papilloma Virus (OHPV) in people living with HIV (PLWHIV) in the East African region. The objective of this study was to document the prevalence and types OHPV infection in a large cohort of PLWHIV attending an urban HIV clinic in Eastern Africa. Methods: This was a cross-sectional study among 1,715 participants of the Makerere University Joint AIDS Program clinic, located in Kampala, Uganda, in East Africa. A salivary sample was collected from which DNA was extracted and subjected to a Polymerase Chain Reaction (PCR) based typing. Data analysis was carried out among participants with complete data (n = 1,243) and relied on descriptive statistics (frequencies, percentages), bivariate testing and multivariate regression modeling, using a conventional p < 0.05 statistical significance threshold. Results: Participants had a mean age of 45 (SD = 10) years, most (69%) were female, and 67% were HPV positive. There was no association between participants' age or gender and the likelihood of them being diagnosed with HPV infection in this study. HPV type 45 was the most frequently (16%) identified HPV, while HPV type 18 (5%) and HPV type 16 (2.3%) were less frequently identified. Most of the HPV positive samples had more than one HPV type detected. Conclusion: This study highlights the high prevalence of OHPV among PLWHIV, with HPV type 45 being the most frequently detected type, and smaller frequencies of vaccine targeted HPV 16 and HPV 18. Our findings highlight the need for continued surveillance and typing of circulating OHPV strains, particularly among PLWHIV, to inform evidence-based preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.